The National Institute for Health and Care Excellence updated its Guide to the Processes of Technology Appraisal as it looks to meet higher demand for quicker technology appraisals.
While the health body made the changes under mounting pressure sign off on more appraisals with less funding, according to a pharmaphorum report, it looks to maintain the integrity of the process.
However, the transitional phase has been a bumpy one, and the future remains uncertain on how the updated appraisal process will ultimately play out.
“There are questions for NICE, too,” the pharmaphorum report states. “How much sway will the final technical report have with the Appraisal Committee or will the committee stage itself become simply a rubber stamp? And how will NICE deal with the problem of companies have to deal with even more immature trial data if appraisals are to start even earlier?”